E. Carmina, S. Bucchieri, P. Mansueto, G. Rini, M. Ferin and R. A. Lobo, “Circulating Levels of Adipose Products and Differences in Fat Distribution in the Ovulatory and Anovulatory Phenotypes of Polycystic Ovary Syndrome,” Fertility and Sterility, Vol. 91, No. 4, 2009, pp. 1332-1335. doi:10.1016/j.fertnstert.2008.03.007

has been cited by the following article:

• TITLE: Serum Adiponectin levels in Different Phenotypes of Polycystic Ovary Syndrome

  AUTHORS: Carolina Fux Otta, Paula Szafryk de Mereshian, Raquel Kaplan, Gabriel Santino Iraci, Silvia Ojeda, José Ochoa, Andrés Albrecht, Natalia Filipone, Marta Fiol de Cuneo

  KEYWORDS: Polycystic Ovary Syndrome; Phenotypes; Adiponectin

  JOURNAL NAME: Open Journal of Endocrine and Metabolic Diseases, Vol.2 No.4, November 30, 2012

  ABSTRACT: Objectives: to evaluate and compare serum adiponectin levels in different phenotypes of polycystic ovary syndrome (PCOS) and to investigate their correlation with endocrine and metabolic parameters. Material and methods: we studied 5 groups of patients: A (n = 20): H (hyperandrogenism) + O (oligoanovulation) + P (polycystic ovary) [classic phenotype]; B (n = 17): H + O [classic phenotype but normal ovaries]; C (n = 15): H + P [Ovulatory phenotype]; D (n = 17): O + P [Normoandrogenic phenotype]; and E (n = 16) control group. Body mass index, waist circumference, waist/hip ratio, blood pressure and hirsutism were evaluated. Serum concentrations of adiponectin, insulin, Creactive protein, SHBG, androgens and lipids were measured. Oral glucose tolerance test was performed. Results: there were no differences between the groups in terms of age and BMI. Total cholesterol, LDL-C and triglyceride levels were higher in phenotype A than in C (P P = 0.03). HOMA-IR, insulin and glucose/insulin ratio were significantly higher in phenotypes A and D vs C and E (P P P